Medical device GTM organizations operate in a highly regulated landscape where compliance is non-negotiable, technical product portfolios demand deep expertise, and sales involve navigating diverse stakeholders from surgeons to IDNs and procurement teams. Every sales interaction risks audits from outdated content or misapplied clinical data, while channel partners require consistent training to promote products effectively.​

Surveys reveal strong impact: 65% of life sciences customers achieve greater use of approved content with platforms like Highspot, 70% deliver more consistent messaging, and 30% boost rep confidence in buyer conversations. Challenges persist with rapid product launches, evolving trial data, and group-based purchasing decisions that demand adaptive pitches.​

Leading teams overcome this through compliant tools like AutoDocs for error-free proposals, automatic content expiry, persona-specific Sales Plays, AI role-play for training, and Instant Answers for real-time queries on indications or trials. AI agents ensure governed innovation without HIPAA or MDR risks, enabling mobile access and coaching at scale.

Download the report to learn how med device leaders ensure compliant, scalable GTM execution from OR to IDN and accelerate revenue growth.​